MedTrace Logo

The Use of Laser in the Treatment of Atrophic Vulvovaginitis

NCT04297319 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-08-09

No results posted yet for this study

Summary

This study evaluates the efficacy and security of laser for atrophy treatment. Half of participants will receive the laser treatment and the other half placebo.

Conditions

  • Lasers
  • Atrophy of Vagina
  • Atrophy Vulva

Interventions

PROCEDURE

Laser diiodo

3 laser diiodo procedures of 5-10 minutes at intervals of 4 weeks It is an outpatient procedure, not anesthesia required.

PROCEDURE

Laser Placebo

3 laser diiodo procedures of 5-10 minutes at intervals of 4 weeks. It is an outpatient procedure, not anesthesia required.

Sponsors & Collaborators

  • Hospital Italiano de Buenos Aires

    lead OTHER

Principal Investigators

  • claudia E Marchitelli, MD · Hospital Italiano de Buenos Aires, Argentina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-20
Primary Completion
2021-05-01
Completion
2021-12-01

Countries

  • Argentina

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04297319 on ClinicalTrials.gov